DIABETIC KETOACIDOSIS (DKA): A GUIDE TO DKA

(Note: For PDF File Swipe To The End Of Article)

Introduction

Diabetic ketoacidosis (DKA) is one of the most serious acute complications of diabetes mellitus. It is a potentially life-threatening metabolic emergency that develops when the body does not have enough effective insulin to control blood glucose levels and prevent excessive ketone production. The condition is characterized by hyperglycemia or a history of diabetes, increased ketone levels in the blood or urine, and metabolic acidosis.

DKA occurs most commonly in people with type 1 diabetes mellitus, but it can also develop in individuals with type 2 diabetes. In some cases, it is the first manifestation of previously undiagnosed diabetes. The condition may develop rapidly, sometimes within hours, and requires prompt recognition and emergency hospital treatment.

Under normal circumstances, insulin allows glucose to enter insulin-sensitive cells and helps regulate the production and utilization of energy. When insulin is severely deficient, the body begins breaking down stored fat to meet its energy requirements. This process produces ketone bodies, which are acidic substances. When ketones accumulate faster than the body can eliminate or buffer them, metabolic acidosis develops.

At the same time, insulin deficiency and increased stress hormones stimulate the liver to release more glucose into the bloodstream. Excess glucose is lost in the urine, taking water and electrolytes with it. Consequently, patients develop dehydration, electrolyte disturbances, and impaired organ function.

The combination of dehydration, metabolic acidosis, electrolyte abnormalities, and disturbed cellular metabolism makes DKA a medical emergency. Without timely treatment, it may progress to severe weakness, confusion, coma, and death.

Early diagnosis and appropriate management substantially improve outcomes. Understanding the causes, clinical features, diagnostic criteria, treatment principles, and preventive measures is therefore essential for healthcare professionals, medical students, and people living with diabetes.

1. Definition of Diabetic Ketoacidosis

Diabetic ketoacidosis is an acute metabolic complication of diabetes mellitus characterized by three major abnormalities:

• Diabetes or elevated blood glucose, although glucose may not be markedly elevated in some cases.
• Increased production and accumulation of ketone bodies.
• Metabolic acidosis caused primarily by the accumulation of ketoacids.

These abnormalities occur mainly because of insufficient effective insulin activity combined with increased counterregulatory hormones, including glucagon, cortisol, catecholamines, and growth hormone.

Insulin deficiency promotes the breakdown of fat into free fatty acids. These fatty acids reach the liver, where they are converted into ketone bodies. Excess ketones lower blood pH and consume the body's bicarbonate buffering capacity.

Meanwhile, increased hepatic glucose production and reduced peripheral glucose utilization contribute to hyperglycemia. The resulting glucose loss through the kidneys causes osmotic diuresis, dehydration, and electrolyte depletion.

DKA is different from uncomplicated hyperglycemia because it involves significant ketone accumulation and metabolic acidosis. A patient may have elevated blood glucose without DKA, while another patient may develop DKA with a glucose concentration below the usual diagnostic threshold.

2. Types of Diabetes Associated With DKA

A. Type 1 Diabetes Mellitus

Type 1 diabetes is strongly associated with DKA because the pancreas produces little or no insulin as a result of the destruction of insulin-producing beta cells.

People with type 1 diabetes depend on externally administered insulin. If insulin delivery stops or becomes insufficient, ketone production can increase rapidly.

Common situations that increase risk include missed insulin doses, insulin pump failure, infection, and newly developing diabetes.

DKA may be the first indication that a person has type 1 diabetes, particularly in children and adolescents.

B. Type 2 Diabetes Mellitus

Although DKA is more commonly associated with type 1 diabetes, it can also occur in type 2 diabetes.

People with type 2 diabetes may develop significant insulin deficiency during severe infection, physiological stress, or other acute illnesses. Some patients also experience temporary or persistent impairment of pancreatic beta-cell function.

Obesity and insulin resistance do not completely protect an individual against DKA. The decisive factor is whether effective insulin activity is sufficient to suppress excessive ketone production.

C. Previously Undiagnosed Diabetes

In some patients, DKA is the first clinical presentation of diabetes mellitus.

Before the emergency develops, the patient may experience increased thirst, frequent urination, fatigue, blurred vision, and unexplained weight loss. These symptoms may initially be overlooked or mistaken for a minor illness.

When insulin deficiency becomes severe, the patient develops nausea, vomiting, abdominal pain, dehydration, and deep breathing.

Recognizing these symptoms early can help prevent severe metabolic deterioration.

D. Euglycemic Diabetic Ketoacidosis

Euglycemic DKA is a form of DKA in which blood glucose is not markedly elevated, commonly below 200 mg/dL (11.1 mmol/L), despite significant ketonemia and metabolic acidosis.

It can occur during pregnancy, prolonged fasting, reduced food intake, alcohol-related illness, and treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Because glucose may appear relatively normal, clinicians can overlook the diagnosis if they rely on glucose measurements alone.

Important clinical principle: A normal or moderately elevated glucose reading does not exclude DKA when symptoms and risk factors suggest the possibility of ketoacidosis.

3. Epidemiology and Risk Factors

DKA can occur in different age groups, although its distribution varies according to the type of diabetes and the population being studied.

It is frequently encountered in children, adolescents, and young adults with type 1 diabetes. However, adults and older individuals are also at risk, particularly during acute illness or when insulin treatment becomes inadequate.

Important risk factors include:

• Type 1 diabetes mellitus.
• Previously undiagnosed diabetes.
• Missed or inadequate insulin doses.
• Infection, including pneumonia and urinary tract infection.
• Insulin pump malfunction or interruption of insulin delivery.
• Severe physiological stress, including surgery and major injury.
• Acute myocardial infarction or stroke.
• Persistent vomiting and inadequate fluid intake.
• Pregnancy in a person with diabetes.
• Use of SGLT2 inhibitors in susceptible individuals.
• Certain medications, including corticosteroids, that can worsen glucose control.
• Limited access to insulin, diabetes supplies, or medical care.
• Previous episodes of DKA.

The presence of a risk factor does not mean that DKA will definitely occur. However, understanding these factors helps identify individuals who need closer monitoring during illness.

4. Causes and Precipitating Factors

DKA usually develops when insulin activity becomes insufficient to meet the body's metabolic requirements. Several conditions can trigger or accelerate this process.

A. Insufficient Insulin

Insulin deficiency is the central mechanism responsible for DKA.

In people with type 1 diabetes, missing prescribed insulin or interrupting insulin delivery can rapidly produce a state of severe insulin deficiency.

In other patients, insulin requirements increase during illness, and their usual treatment may no longer be sufficient.

Examples include:

• Missed insulin injections.
• Incorrect insulin administration.
• Expired or improperly stored insulin.
• Blocked insulin pump tubing.
• Pump cannula displacement.
• Failure to recognize increasing insulin requirements during illness.

Insulin should not be stopped simply because a person is eating less. People who use insulin need individualized sick-day instructions from their diabetes team.

B. Infection

Infection is an important precipitating factor for DKA.

Conditions such as pneumonia, urinary tract infection, skin infection, and systemic infection increase the production of stress hormones.

These hormones stimulate hepatic glucose production and increase insulin resistance. Consequently, the body may require more insulin than usual.

If insulin requirements are not met, hyperglycemia and ketone production can worsen.

Fever, chills, cough, painful urination, and other signs of infection should therefore be assessed in patients presenting with DKA.

C. Newly Diagnosed Diabetes

Some individuals develop DKA before diabetes has been diagnosed.

Progressive insulin deficiency may initially cause excessive thirst, frequent urination, fatigue, and weight loss. If the symptoms are not recognized, metabolic decompensation can occur.

This is particularly important in children, adolescents, and young adults, although it can occur at any age.

D. Acute Medical Stress

Severe physiological stress can increase insulin requirements and precipitate DKA.

Examples include:

• Myocardial infarction.
• Stroke.
• Major surgery.
• Serious trauma.
• Acute pancreatitis.
• Severe systemic illness.

In these circumstances, the combined effects of stress hormones, inflammation, and insulin resistance can disturb glucose regulation.

E. Medications

Certain medications can contribute to hyperglycemia or alter the presentation of DKA.

SGLT2 inhibitors are particularly important because they can increase the risk of DKA, sometimes without marked hyperglycemia.

Corticosteroids may increase blood glucose and insulin requirements. Some antipsychotic medications can also worsen glucose regulation.

Medication-related risk depends on the patient's underlying condition, treatment regimen, and other contributing factors.

Patients should not independently discontinue or modify prescribed medicines without appropriate clinical advice, except when following an established emergency or sick-day plan.

5. Pathophysiology of Diabetic Ketoacidosis

Understanding the pathophysiology of DKA explains why the disease causes hyperglycemia, ketonemia, acidosis, dehydration, and electrolyte disturbances.

Step 1: Decreased Effective Insulin Activity

The process begins when insulin activity becomes insufficient.

Insulin normally promotes glucose utilization and suppresses hepatic glucose production, lipolysis, and ketogenesis.

When insulin activity falls, these regulatory effects are lost.

At the same time, counterregulatory hormones increase. Glucagon, cortisol, catecholamines, and growth hormone promote a metabolic state that favors glucose production and fat breakdown.

Step 2: Increased Hepatic Glucose Production

The liver produces glucose through glycogenolysis and gluconeogenesis.

Glycogenolysis is the breakdown of stored glycogen into glucose. Gluconeogenesis is the formation of glucose from non-carbohydrate substances, including lactate, glycerol, and certain amino acids.

In DKA, these processes become excessive because of insulin deficiency and increased counterregulatory hormone activity.

At the same time, glucose utilization in insulin-sensitive tissues is impaired.

The combined effects produce hyperglycemia.

Step 3: Osmotic Diuresis

When blood glucose exceeds the kidneys' capacity to reabsorb all the filtered glucose, glucose appears in the urine.

Glucose in the urine increases the amount of water lost through the kidneys. This process is called osmotic diuresis.

Water loss is accompanied by urinary losses of sodium, potassium, chloride, phosphate, and other electrolytes.

The patient develops excessive urination, thirst, dehydration, and progressive reduction in circulating blood volume.

Step 4: Increased Lipolysis

Under normal conditions, insulin suppresses the breakdown of stored triglycerides in adipose tissue.

During DKA, this suppression is reduced. Hormone-sensitive lipase activity increases, releasing free fatty acids and glycerol.

Free fatty acids are transported to the liver, where they become substrates for ketone production.

Glycerol can also contribute to hepatic gluconeogenesis, further increasing glucose production.

Step 5: Ketone Body Production

The liver converts free fatty acids into acetyl-coenzyme A through beta-oxidation.

When carbohydrate metabolism is disrupted and insulin is deficient, the liver directs more of this substrate toward ketogenesis.

The major ketone bodies are:

• Beta-hydroxybutyrate.
• Acetoacetate.
• Acetone.

Beta-hydroxybutyrate is usually the predominant ketone measured during significant DKA.

Acetoacetate and beta-hydroxybutyrate contribute to metabolic acidosis. Acetone is volatile and can produce a characteristic fruity odor on the breath.

Step 6: Development of Metabolic Acidosis

As ketoacids accumulate, they release hydrogen ions.

The body's bicarbonate buffer system helps neutralize these acids, but continued ketone production consumes bicarbonate faster than it can be replenished.

Consequently, blood bicarbonate decreases and blood pH falls.

This produces a high-anion-gap metabolic acidosis.

The respiratory system attempts to compensate by increasing the depth and rate of breathing. In severe cases, patients develop Kussmaul respiration, characterized by deep, labored breathing.

Step 7: Electrolyte Disturbances

DKA causes substantial total-body electrolyte depletion, particularly potassium.

However, the serum potassium concentration at presentation may be low, normal, or high.

Insulin deficiency, hypertonicity, and acid-base disturbances can shift potassium from inside cells into the extracellular fluid. At the same time, urinary losses reduce total-body potassium stores.

When insulin treatment begins and acidosis improves, potassium moves back into cells, potentially causing a dangerous fall in serum potassium.

This is why potassium must be monitored carefully throughout treatment.

Step 8: Impaired Organ Function

Severe dehydration reduces circulating blood volume and can decrease kidney perfusion.

The resulting acute kidney injury may impair the elimination of glucose, ketones, and other metabolic waste products.

Poor circulation, severe acidosis, and electrolyte abnormalities can affect the heart, brain, and other organs.

Without treatment, the patient may progress to shock, altered consciousness, coma, and death.

6. Clinical Features of Diabetic Ketoacidosis

The clinical presentation of DKA ranges from mild symptoms to a life-threatening emergency.

Symptoms may develop over several hours or a few days, although the course varies depending on the cause and severity of insulin deficiency.

A. Early Symptoms

Early manifestations often reflect hyperglycemia and dehydration.

Common symptoms include:

• Excessive thirst, known as polydipsia.
• Frequent urination, known as polyuria.
• Increased fatigue.
• Generalized weakness.
• Dry mouth.
• Blurred vision.
• Unexplained weight loss.
• Reduced energy and concentration.

These symptoms may be present for several days before the patient recognizes that a serious metabolic problem is developing.

B. Gastrointestinal Symptoms

As ketones accumulate and acidosis worsens, gastrointestinal symptoms may become prominent.

These include:

• Nausea.
• Repeated vomiting.
• Abdominal pain.
• Reduced appetite.
• Inability to tolerate oral fluids.

Abdominal pain can be significant and may resemble an acute abdominal disorder.

Although DKA itself can cause abdominal discomfort, clinicians must also investigate possible precipitating conditions, including pancreatitis, appendicitis, and other abdominal emergencies when indicated.

C. Signs of Dehydration

Osmotic diuresis produces substantial fluid loss.

Clinical findings may include:

• Dry mucous membranes.
• Intense thirst.
• Tachycardia.
• Reduced skin turgor.
• Weakness.
• Reduced urine output in advanced dehydration.
• Low blood pressure in severe cases.
• Dizziness or faintness.

The severity of dehydration varies according to the duration of illness, oral fluid intake, kidney function, and the extent of urinary losses.

D. Kussmaul Respiration

Kussmaul respiration is a characteristic manifestation of significant metabolic acidosis.

The patient breathes deeply and often rapidly in an attempt to reduce carbon dioxide levels and partially compensate for the fall in blood pH.

This breathing pattern is different from ordinary rapid breathing caused by anxiety or mild exertion.

Kussmaul respiration should raise concern for severe metabolic disturbance, particularly when accompanied by vomiting, dehydration, and diabetes.

E. Fruity Breath Odor

Some patients develop a fruity or acetone-like odor on their breath.

This occurs because acetone, a volatile ketone body, is exhaled through the lungs.

The odor may support clinical suspicion, but its absence does not exclude DKA.

F. Neurological Manifestations

As dehydration, hypertonicity, and acidosis become more severe, neurological function may deteriorate.

Possible findings include:

• Headache.
• Irritability.
• Difficulty concentrating.
• Drowsiness.
• Confusion.
• Reduced responsiveness.
• Stupor or coma in severe cases.

Altered mental status is a warning sign that requires urgent assessment.

G. Cardiovascular Manifestations

Severe fluid depletion can produce tachycardia, low blood pressure, and impaired peripheral perfusion.

Electrolyte disturbances may also affect cardiac electrical activity.

Severe potassium abnormalities can cause dangerous arrhythmias, making continuous or repeated cardiovascular assessment important in patients with significant metabolic derangement.

7. Diagnostic Criteria for Diabetic Ketoacidosis

The diagnosis of DKA requires an integrated assessment of clinical findings, blood glucose, ketone levels, and acid-base status.

The 2024 international consensus report identifies three essential diagnostic components in adults.

A. Diabetes or Hyperglycemia

The first component is either:

• A blood glucose concentration of at least 200 mg/dL (11.1 mmol/L), or
• A previous diagnosis of diabetes, regardless of the presenting glucose concentration.

This broader definition recognizes that DKA can occur without marked hyperglycemia.

B. Increased Ketones

The second component is significant ketonemia or ketonuria.

A blood beta-hydroxybutyrate concentration of at least 3.0 mmol/L strongly supports the diagnosis when the other required criteria are present.

Urine ketone testing can be useful when blood ketone testing is unavailable, but it has limitations.

Urine tests primarily detect acetoacetate rather than beta-hydroxybutyrate. They may underestimate ketone accumulation early in DKA and remain positive or appear more strongly positive during recovery.

Blood beta-hydroxybutyrate measurement is generally preferred when available.

C. Metabolic Acidosis

The third component is metabolic acidosis, demonstrated by either:

• Venous blood pH below 7.30, or
• Serum bicarbonate below 18 mmol/L.

The findings must be interpreted in the context of the clinical presentation and other laboratory results.

DKA is not diagnosed solely from a high glucose concentration or a positive urine ketone result.

Diagnostic Summary

A diagnosis of DKA requires evidence of diabetes or hyperglycemia, increased ketones, and metabolic acidosis.

All three components are important because similar symptoms can occur in other medical conditions, including starvation ketosis, alcoholic ketoacidosis, lactic acidosis, and toxic ingestion.

8. Severity Classification

DKA is commonly classified as mild, moderate, or severe according to the degree of ketonemia, metabolic acidosis, and neurological impairment.

Mild DKA

Mild DKA generally involves:

• Blood pH above 7.25 but below 7.30, or bicarbonate of 15–18 mmol/L.
• Beta-hydroxybutyrate of approximately 3–6 mmol/L.
• Usually preserved alertness.

Patients still require urgent medical assessment and treatment.

Moderate DKA

Moderate DKA generally involves:

• Blood pH of approximately 7.00–7.25.
• Bicarbonate of 10 to below 15 mmol/L.
• Significant ketonemia.
• Possible drowsiness or other changes in mental status.

More intensive monitoring may be required.

Severe DKA

Severe DKA is characterized by more profound metabolic abnormalities, such as:

• Blood pH below 7.00.
• Bicarbonate below 10 mmol/L.
• Markedly elevated ketone levels.
• Stupor, coma, or other serious neurological impairment in some patients.

Severe cases may require intensive care.

The classification is a clinical guide rather than a substitute for individual assessment. The appropriate care setting depends on the patient's overall condition, comorbidities, vital signs, and response to treatment.

9. Investigations for Diabetic Ketoacidosis

Laboratory investigations confirm DKA, assess its severity, identify complications, and help determine the precipitating cause.

A. Blood Glucose

Blood glucose testing identifies hyperglycemia and helps monitor the response to treatment.

However, glucose measurement alone cannot confirm or exclude DKA.

Patients taking SGLT2 inhibitors and those with pregnancy-associated or other forms of euglycemic DKA may have relatively modest glucose elevations.

B. Blood Ketones

Measurement of beta-hydroxybutyrate is particularly useful for diagnosing and monitoring DKA.

Elevated levels indicate increased ketone production.

A reduction in beta-hydroxybutyrate during treatment helps demonstrate that ketogenesis is resolving.

C. Venous Blood Gas

A venous blood gas can provide information about blood pH and bicarbonate status.

It helps determine the severity of metabolic acidosis and monitor its correction.

An arterial blood gas is not routinely necessary in every patient but may be indicated for specific respiratory or other clinical concerns.

D. Serum Electrolytes

Electrolytes are essential investigations because DKA can cause significant disturbances in sodium, potassium, chloride, and bicarbonate.

Potassium deserves particular attention because both low and high serum concentrations can be dangerous.

Repeated electrolyte measurements are required during treatment because insulin administration and fluid replacement can rapidly change measured concentrations.

E. Renal Function Tests

Blood urea nitrogen and creatinine help assess kidney function and the effects of dehydration.

Elevated creatinine may indicate reduced kidney perfusion or acute kidney injury.

Renal function also influences fluid management, electrolyte replacement, and the safety of some medications.

F. Anion Gap

The anion gap helps identify high-anion-gap metabolic acidosis.

It is commonly calculated as:

Anion gap = Sodium − (Chloride + Bicarbonate)

The result must be interpreted according to the laboratory's reference range and the patient's clinical circumstances.

Although the anion gap is useful in the initial assessment, direct measurement of blood ketones is preferred for monitoring DKA resolution when available.

G. Complete Blood Count

A complete blood count may help identify anemia or provide information relevant to suspected infection.

Leukocytosis can occur because of physiological stress and inflammation associated with DKA. Therefore, an elevated white blood cell count does not automatically prove that an infection is present.

Clinical findings and additional investigations should guide the evaluation.

H. Urinalysis

Urinalysis can identify glucose and ketones in urine and may provide clues to urinary tract infection or other urinary abnormalities.

However, urine ketones have limitations compared with blood beta-hydroxybutyrate testing.

I. Additional Investigations

Depending on the clinical presentation, investigations may include:

• Electrocardiography to assess cardiac rhythm and changes associated with electrolyte abnormalities.
• Blood cultures when systemic infection is suspected.
• Urine culture when urinary infection is suspected.
• Chest imaging when pneumonia or another thoracic condition is suspected.
• Lipase testing when pancreatitis is considered.
• Pregnancy testing when clinically appropriate.
• Cardiac investigations when myocardial infarction is suspected.
• Serum osmolality when hyperosmolarity or overlapping DKA and hyperosmolar hyperglycemic state is suspected.

Investigations should be selected according to the patient's presentation rather than ordered indiscriminately.

10. Differential Diagnosis

Several conditions can resemble DKA because they cause ketones, acidosis, abdominal symptoms, or altered mental status.

A. Hyperosmolar Hyperglycemic State

Hyperosmolar hyperglycemic state (HHS) is another serious complication of diabetes.

HHS usually involves profound hyperglycemia, hyperosmolality, and dehydration without the degree of ketonemia and metabolic acidosis characteristic of DKA.

Neurological disturbances may be prominent.

Some patients have overlapping features of both conditions, so clinicians must assess ketones, pH, bicarbonate, glucose, and osmolality together.

B. Starvation Ketoacidosis

Starvation ketoacidosis develops when prolonged inadequate carbohydrate intake causes increased ketone production.

Glucose may be normal or low, although the degree of acidosis varies.

The history of reduced food intake and the overall laboratory findings help distinguish it from DKA.

C. Alcoholic Ketoacidosis

Alcoholic ketoacidosis may develop in people with heavy alcohol use, particularly after a period of poor food intake and vomiting.

Blood glucose may be low, normal, or elevated.

The patient's history, ketone levels, acid-base status, and associated findings help establish the diagnosis.

D. Lactic Acidosis

Lactic acidosis occurs when lactate accumulates because of impaired tissue perfusion, altered metabolism, certain medications, or other underlying conditions.

It may coexist with DKA, particularly in critically ill patients.

E. Toxic Ingestion

Certain toxic substances, including methanol and ethylene glycol, can cause severe metabolic acidosis.

Suspected poisoning requires a separate urgent evaluation and specific treatment.

Correct identification of the underlying disorder is essential because management differs among these conditions.

11. Treatment of Diabetic Ketoacidosis

DKA is a medical emergency that generally requires hospital admission.

The principal treatment goals are to restore circulating fluid volume, stop excessive ketone production, correct electrolyte abnormalities, treat the precipitating cause, and prevent complications.

Treatment should be guided by trained healthcare professionals using an appropriate hospital protocol.

A. Initial Assessment and Stabilization

The first step is assessment of the patient's airway, breathing, circulation, mental status, and vital signs.

Clinicians evaluate the severity of dehydration, evidence of shock, respiratory abnormalities, and potential complications.

Intravenous access is established, and initial laboratory investigations are obtained.

Patients with severe DKA, significant neurological impairment, shock, or serious associated illness may require intensive care.

B. Intravenous Fluid Replacement

Fluid replacement is a central component of DKA treatment.

Osmotic diuresis causes substantial water and electrolyte loss. Restoring circulating volume improves tissue perfusion and kidney function.

Intravenous isotonic saline or an appropriate balanced crystalloid solution is commonly used, depending on the patient's condition and local protocol.

The rate and total amount of fluid depend on factors such as:

• Degree of dehydration.
• Blood pressure and circulation.
• Kidney function.
• Cardiac function.
• Serum sodium and osmolality.
• Age and body weight.
• Risk of fluid overload.

Older adults and patients with heart failure or kidney disease require particular caution.

Fluid therapy is monitored carefully to avoid inadequate resuscitation and complications associated with overly rapid or excessive replacement.

C. Insulin Therapy

Insulin is required to suppress lipolysis and ketogenesis, reduce hepatic glucose production, and correct the metabolic abnormalities responsible for DKA.

Intravenous insulin is commonly used in adults with significant DKA under a monitored hospital protocol.

Selected patients with uncomplicated mild or moderate DKA may be managed with frequent subcutaneous rapid-acting insulin under an appropriate clinical protocol and close supervision.

Insulin treatment must be coordinated with potassium assessment and fluid replacement.

Insulin drives potassium into cells. If serum potassium is dangerously low, insulin may worsen hypokalemia and increase the risk of cardiac arrhythmias.

For this reason, clinicians assess and correct significant potassium deficiency before initiating or continuing insulin according to the relevant treatment protocol.

D. Potassium Replacement

Potassium management is one of the most important aspects of DKA treatment.

Despite possible normal or elevated serum potassium at presentation, total-body potassium is usually depleted.

When insulin is administered and acidosis improves, potassium shifts into cells. Serum potassium can therefore fall rapidly.

Clinicians monitor potassium repeatedly and replace it when indicated, taking kidney function and urine output into account.

If potassium is severely low, insulin may need to be delayed temporarily while potassium is corrected under medical supervision.

Excessive potassium replacement is also dangerous. The goal is to maintain potassium within a safe range throughout treatment.

E. Dextrose Administration

As blood glucose falls during insulin therapy, dextrose may need to be added to intravenous fluids.

This allows insulin to continue suppressing ketone production while reducing the risk of hypoglycemia.

An important principle of DKA management is that normalizing blood glucose does not necessarily mean that ketoacidosis has resolved.

Insulin treatment is therefore guided by ketone levels, acid-base status, glucose, and electrolyte measurements rather than glucose alone.

F. Bicarbonate Therapy

Bicarbonate is not routinely recommended for most patients with DKA.

Fluid replacement and insulin usually correct the underlying ketoacidosis.

Bicarbonate may be considered in selected cases of extreme acidemia under specialist supervision, because it can produce complications, including potassium shifts and other metabolic disturbances.

The decision depends on the severity of acidemia and the patient's overall clinical condition.

G. Phosphate Replacement

Phosphate levels may fall during DKA and its treatment.

Routine phosphate replacement is not required in every patient.

Replacement may be considered when severe phosphate depletion is associated with clinically important muscle weakness, respiratory compromise, cardiac dysfunction, or other specific indications.

Excessive phosphate administration can cause hypocalcemia and other complications, so replacement requires monitoring.

H. Treatment of the Underlying Cause

Correcting the metabolic abnormalities is only one part of treatment.

The precipitating factor must also be identified and managed.

Examples include:

• Antibiotics when a bacterial infection is appropriately diagnosed or strongly suspected.
• Assessment and treatment of myocardial infarction.
• Correction of insulin pump malfunction.
• Review of insulin administration and access to insulin.
• Management of pancreatitis or another acute illness.
• Appropriate assessment of medication-related risks.
• Obstetric and medical management when DKA occurs during pregnancy.

Antibiotics are not automatically required for every episode of DKA. They are used when indicated by the clinical assessment.

I. Monitoring During Treatment

Patients require repeated clinical and laboratory assessments.

Monitoring commonly includes:

• Blood glucose.
• Blood beta-hydroxybutyrate when available.
• Serum potassium and other electrolytes.
• Venous pH and bicarbonate.
• Kidney function.
• Vital signs and circulation.
• Fluid intake and urine output.
• Neurological status.
• Signs of hypoglycemia or other treatment complications.

Monitoring frequency depends on the severity of DKA and the treatment setting.

The purpose is to ensure that ketogenesis is suppressed, acidosis is resolving, circulation is restored, and electrolyte disturbances are corrected safely.

12. Criteria for Resolution of DKA

DKA resolution is assessed using clinical and biochemical findings.

The 2024 international consensus report identifies resolution by:

• Plasma beta-hydroxybutyrate below 0.6 mmol/L, and
• Venous pH of at least 7.30 or serum bicarbonate of at least 18 mmol/L.

Blood glucose is ideally below 200 mg/dL at resolution, but glucose normalization alone is insufficient to establish that DKA has resolved.

The anion gap is not preferred as the sole marker of resolution because treatment-related changes, including hyperchloremic metabolic acidosis, can complicate interpretation.

Before stopping intravenous insulin, clinicians must ensure that an appropriate subcutaneous insulin plan is established when indicated. Basal insulin should be coordinated with the transition according to the patient's regimen and hospital protocol to prevent recurrent ketosis.

The patient should also be clinically stable, with a plan for nutrition, monitoring, and management of the precipitating illness.

13. Complications of Diabetic Ketoacidosis

DKA can produce complications because of the disease itself, severe dehydration, electrolyte abnormalities, and treatment-related changes.

A. Severe Dehydration

Persistent osmotic diuresis causes substantial water loss.

Severe dehydration reduces circulating blood volume and can impair blood flow to vital organs.

If untreated, it may progress to shock and organ dysfunction.

B. Electrolyte Imbalance

Potassium, sodium, phosphate, and other electrolyte abnormalities can occur during DKA.

Potassium disturbances are particularly dangerous because they can affect cardiac conduction and muscle function.

Both low and high potassium concentrations may cause life-threatening arrhythmias.

C. Acute Kidney Injury

Dehydration can reduce kidney perfusion, leading to acute kidney injury.

Reduced kidney function can also interfere with the elimination of acids and affect electrolyte balance.

Kidney function often improves with appropriate treatment when the injury is primarily related to reversible volume depletion, but some patients may experience more serious complications.

D. Cardiac Arrhythmias

Severe electrolyte abnormalities, acidosis, and underlying cardiovascular disease may contribute to abnormal heart rhythms.

Monitoring and correction of potassium and other metabolic disturbances are essential for reducing this risk.

E. Cerebral Edema and Neurological Injury

Cerebral edema is a particularly important concern in children and adolescents with DKA, although neurological complications can also occur in adults.

It may be associated with the disease process or changes during treatment.

Warning signs include worsening headache, altered mental status, repeated vomiting, seizures, and changes in neurological function.

These findings require immediate clinical evaluation.

F. Hypoglycemia

Insulin treatment can cause blood glucose to fall excessively.

Dextrose administration, appropriate insulin adjustment, and frequent glucose monitoring help reduce this risk.

G. Hypokalemia

Potassium can fall rapidly during insulin therapy.

Severe hypokalemia may cause muscle weakness, respiratory impairment, and dangerous cardiac arrhythmias.

Frequent potassium monitoring is therefore essential.

H. Hyperchloremic Metabolic Acidosis

A non-anion-gap, hyperchloremic metabolic acidosis can develop during treatment, particularly after substantial chloride-rich fluid administration.

This may persist after ketone production has resolved.

Clinicians distinguish this condition from ongoing ketoacidosis using ketone measurements and the broader biochemical picture.

I. Thromboembolic Complications

Dehydration and the associated inflammatory state can contribute to increased thrombotic risk.

The need for preventive measures depends on the patient's risk factors, mobility, and hospital protocol.

J. Death

Without timely treatment, severe DKA can progress to shock, serious electrolyte disturbances, coma, and death.

Prompt diagnosis and appropriate management greatly improve the likelihood of recovery.

14. Diabetic Ketoacidosis in Children

DKA is an important cause of emergency hospital admission among children with type 1 diabetes.

It may occur at the time of initial diagnosis or in a child who already has diabetes.

Common presenting features include excessive thirst, frequent urination, weight loss, vomiting, abdominal pain, dehydration, and deep breathing.

Young children may be unable to explain their symptoms clearly. Parents and caregivers may initially attribute the symptoms to an infection or gastrointestinal illness.

Children with suspected DKA require urgent pediatric assessment and carefully supervised treatment.

Fluid replacement, insulin administration, electrolyte monitoring, and neurological assessment must follow pediatric protocols.

Cerebral injury is a major concern in pediatric DKA. New or worsening headache, irritability, altered consciousness, seizures, or other neurological changes require immediate evaluation.

Education of parents, school staff, and caregivers can help identify early symptoms and reduce delays in treatment.

15. DKA During Pregnancy

Pregnancy increases metabolic complexity and can increase vulnerability to DKA in people with diabetes.

Hormonal changes during pregnancy increase insulin resistance, particularly as pregnancy progresses. Insulin requirements may change, and illness can rapidly disturb glucose regulation.

DKA may develop at lower glucose concentrations during pregnancy than in other circumstances.

This makes it especially important not to dismiss symptoms because blood glucose appears only moderately elevated.

Possible symptoms include nausea, vomiting, abdominal discomfort, excessive thirst, weakness, and abnormal breathing.

Pregnancy-associated DKA is an emergency requiring coordinated obstetric, diabetes, and critical-care assessment when indicated.

Management focuses on maternal stabilization, fluid and electrolyte correction, insulin treatment, identification of the precipitating cause, and appropriate fetal monitoring.

Pregnant patients with diabetes should receive individualized sick-day guidance and clear instructions about when to seek emergency care.

16. Euglycemic DKA and SGLT2 Inhibitors

SGLT2 inhibitors are medications that reduce blood glucose by increasing urinary glucose excretion.

Although these medicines have important benefits for selected patients, they are associated with an increased risk of DKA in susceptible individuals.

Because glucose is lost in the urine, DKA can develop without the marked hyperglycemia traditionally associated with the condition.

Risk may increase during acute illness, prolonged fasting, dehydration, major surgery, or substantial reduction in insulin.

Healthcare professionals should consider euglycemic DKA when a patient taking an SGLT2 inhibitor develops nausea, vomiting, abdominal pain, unexplained acidosis, or other concerning symptoms.

Blood ketones and acid-base status are particularly important in this situation.

Patients should receive medication-specific sick-day and perioperative instructions from their healthcare team. They should not independently alter insulin or other prescribed treatments without appropriate guidance.

17. Prevention of Diabetic Ketoacidosis

Prevention is an essential part of diabetes care.

Although not every episode can be prevented, education, monitoring, and early treatment of illness can reduce the risk of DKA.

A. Take Insulin as Prescribed

People who require insulin should follow their individualized treatment plan.

Missed doses and interruptions in insulin delivery are important preventable causes of DKA.

Insulin should not be stopped simply because a person is eating less. The appropriate adjustment depends on the insulin regimen, blood glucose, ketone levels, and clinical circumstances.

B. Monitor Blood Glucose

Regular glucose monitoring helps identify worsening hyperglycemia before severe metabolic complications develop.

Monitoring may involve a blood glucose meter or a continuous glucose monitoring system.

Patients should understand their target ranges and know when readings require further action.

C. Check Ketones When Indicated

Blood or urine ketone testing is particularly useful during illness or when DKA symptoms develop.

People with diabetes should follow the testing thresholds and action plan provided by their diabetes team.

Blood ketone testing is generally preferred when available because it directly measures beta-hydroxybutyrate.

D. Follow Sick-Day Rules

Illness can increase insulin requirements and make glucose control more difficult.

An individualized sick-day plan should explain:

• How frequently to check blood glucose.
• When to measure ketones.
• How to maintain fluid intake.
• How to manage insulin during illness.
• Which medications may require temporary adjustment under medical guidance.
• When to contact the diabetes care team.
• When emergency treatment is necessary.

These instructions should be discussed before illness occurs.

E. Maintain Adequate Hydration

Fluid intake helps replace losses caused by fever, vomiting, diarrhea, and excessive urination.

However, patients with heart failure, kidney disease, or prescribed fluid restrictions need individualized advice.

Persistent vomiting or inability to maintain adequate fluid intake warrants prompt medical assessment.

F. Recognize Early Symptoms

People with diabetes and their families should understand the warning signs of DKA.

These include excessive thirst, frequent urination, vomiting, abdominal pain, fruity breath, deep breathing, and unusual drowsiness.

Recognizing these symptoms early can reduce delays in emergency treatment.

G. Maintain Access to Diabetes Supplies

A practical prevention plan includes access to insulin, glucose-monitoring supplies, ketone-testing supplies when indicated, and a way to contact the diabetes care team.

People using insulin pumps should know how to recognize pump failure and follow their prescribed backup plan.

Healthcare professionals should also discuss financial, educational, and practical barriers that may interrupt treatment.

H. Attend Regular Medical Appointments

Regular diabetes reviews help identify difficulties with medication use, glucose monitoring, and sick-day management.

Appointments also provide an opportunity to review insulin doses, device function, associated illnesses, and previous episodes of DKA.

Patients who have experienced DKA may benefit from a structured review of the circumstances that led to the episode.

18. Emergency Warning Signs

DKA should never be managed solely through home remedies or by waiting for symptoms to disappear.

Emergency assessment is required when a person with diabetes develops concerning features such as:

• Repeated vomiting or inability to keep fluids down.
• Significant abdominal pain with other symptoms of DKA.
• Deep or unusually rapid breathing.
• Fruity-smelling breath.
• Severe weakness or dehydration.
• Confusion, unusual drowsiness, or reduced consciousness.
• High blood ketone levels, particularly around 3.0 mmol/L or above.
• High urine ketones, particularly when accompanied by symptoms.
• Symptoms suggestive of DKA even when glucose is not markedly elevated.

If DKA is suspected, seek emergency medical care immediately. Do not delay treatment while attempting to correct the condition independently at home.

19. Prognosis and Recovery

The prognosis of DKA depends on the severity of metabolic abnormalities, the patient's age and underlying health, the precipitating cause, and the speed of treatment.

Many patients recover well when the condition is recognized early and treated appropriately.

Severe cases may require intensive monitoring, particularly when shock, major electrolyte disturbances, kidney injury, or neurological complications are present.

After the acute episode resolves, the focus shifts to preventing recurrence.

This includes reviewing the cause, establishing an appropriate diabetes treatment regimen, ensuring access to insulin and monitoring supplies, and providing education about sick-day management.

Patients whose DKA was the first manifestation of diabetes require a comprehensive diagnostic evaluation and a long-term treatment plan.

Follow-up should also address barriers to treatment, including medication costs, inadequate diabetes education, and difficulties accessing medical care.